Barry Hyman
Barry Hyman
chain companies defensive developing filters market pc produce remain sales start technology throughout
The market is going to remain on the defensive and start to look at this developing technology story. To technology, that story is very important. It filters throughout the whole chain of PC sales to companies that produce chips.
continue hopefully market past political positively react
The market is going to continue to be buffeted by this political story that doesn't go away. If we can get past that, hopefully the market will react positively to the end of a process.
low market patterns trading typical
The market is exhibiting the typical end-of-year patterns of low volume, lackluster trading and little volatility.
clearly divided looking market moderate stock
The market is clearly divided right now. Those who are looking at 2005 expectations think we can see moderate stock gains, those who are looking out at 2006 are more concerned.
likelihood pressures
The likelihood of inflationary pressures is increasing. The likelihood that the (Federal Reserve) is going to do something is increasing.
news today
I think it's emotional, because all the news out today is already known.
decent market rally tremendous week
I think the market had a decent week but without any fundamental backing, the rally doesn't really have tremendous upside.
beginning continue few likely movement seen since weeks
I think the movement we've seen since the beginning of the year, with a few weeks up, a few weeks down, is likely to continue at least through the end of the quarter.
earnings general optimistic picture
I think the picture is optimistic and earnings in general have been better than expected.
bit pressure puts
I think that puts a little bit of pressure on the market.
benefit both companies deals dollars eventually good help helps high marketing merger sector strike terms toward
I think, ... that Pfizer is going to benefit from their merger with Warner-Lambert. I think that makes a very good deal. But most pharmaceutical companies do eventually strike deals with biotech companies in terms of marketing their product. And the genomic companies don't have a lot of cash. They have a lot of high valuations, but they don't have a lot of dollars to spend. So, they usually look toward the pharmaceutical sector to help them out, which usually helps both sectors.
began feeling secure walk week
I think you walk away this week feeling much more secure than you began the week.
acted board federal interest left lower open please properly reserve window
I think the Federal Reserve Board acted properly and left the window open for lower interest rates, which will please the market.
encouraged overly
I was encouraged by today, but not overly so. We need to see a lot more than one day.